Articoli in lingua originale
- Real-Time Continuous Glucose Monitoring and Multiple Insulin Injections Are Effective for Glycemic Control
- Glucagon Is Underprescribed and Underutilized
- DASH and Mediterranean Diets Tie for Best Overall Diet
- Can Oral Insulin Slow Onset of Type 1 Diabetes in High-Risk Patients?
- Oral Insulin Doesn’t Stop Type 1 Diabetes in Those at Risk
- High Vitamin D levels in childhood may cut diabetes risk
- Novo Nordisk takes aim at Eli Lilly with U.S. backing of new diabetes drug
- Decline in Beta-Cell Function Among Adolescents with Type 2 Diabetes Mellitus
- Where There’s Type 1 Diabetes, Celiac Disease May Follow
- FDA approves Novo Nordisk fast-acting insulin Fiasp
- Abbott’s FreeStyle Libre wins FDA nod
- Updated Type 1 Diabetes Treatment Guidelines
- Glycemic Control in Diabetic Patients with Chronic Kidney Disease
- Mixed News on Mortality for Diabetes Patients
- Rates of new diagnosed cases of type 1 and type 2 diabetes on the rise among children, teens
- In Type 1 Diabetes, Patient Training More Important Than Choice of Multiple Insulin Injections vs. Pump
- Many Youth Newly Diagnosed with Diabetes Aren’t Screened for Retinopathy
- Screen time linked to increased diabetes risk in children: study
- Lifelong Extra Weight Predicts Poor Physical Shape in Old Age
- How dietary factors influence disease risk
- 2017 Diabetes Care Standards Issued
- Youth with type 2 diabetes develop complications more often than type 1 peers
- Mediterranean Diet, The Diet Of The 21st Century?
- Managing diabetic retinopathy: ADA releases new position statement
- EU nod for Novo’s new fast-acting insulin
- Progress Toward a “Bionic Pancreas” for Type 1 Diabetics
- Is Social Network Activity Associated with Lower Mortality?
- This Month IS NOT for the Diabetes Community….it’s for Those Who Know Nothing!!!!
- Abbott Receives FDA Approval for the FreeStyle Libre Pro™ System, a Revolutionary Diabetes Sensing Technology for Healthcare Professionals to Use with Their Patients
- FDA Clears Abbott’s Needle-Free CGM For Professional Use
- FDA approves first automated insulin delivery device for type 1 diabetes
- High-Fat Mediterranean Diet Might Cut Risk for CV Events, Breast Cancer, and Diabetes
- Diabetes-Cancer Link Strongest Immediately After Diabetes Diagnosis
- I’ll Have That on Whole Wheat: More Evidence for Whole Grains’ Health Benefits
- Emotions and Diabetes: Should you see a therapist?
- HbA1c variability predicts retinopathy, nephropathy in teens with type 1 diabetes
- Mothers with diabetes more likely to also have anti-fetal brain autoantibodies
- ADA: Just Walk Away From Diabetes
- New, faster-acting insulin from Novo Nordisk improves blood glucose levels in studies
- Bionic Pancreas Reduces Hypoglycemia with Automated Glucagon Delivery #2016ADA
- Pioglitazone Decreases Type 2 Diabetes Risk in Stroke Patients with Insulin Resistance #2016ADA
- Eye study underscores the long-lasting benefits of controlling diabetes
- Abbott Announces Positive Results From Groundbreaking Study Of FreeStyle® Libre System For People With Type 1 Diabetes
- Home Use of a Dual Hormone, Bionic Pancreas Safely Reduces Blood Glucose Levels and Hypoglycemia in Adults While Continuing Normal Daily Activities #2016ADA
- First Type 1 Diabetes Patient in Europe is Free from Insulin Therapy after Undergoing Diabetes Research Institute’s BioHub Transplant Technique
- Artificial Pancreas Success in Type 1 Diabetes in Pregnancy
- Carbs, Spikes and Snack Ideas
- Reaction to the Numbers
- Diabetes Research Institute Celebrates a Decade of Freedom From Insulin Injections for Third Islet Transplant Patient
- Incident Type 2 diabetes and the effect of early regression to normoglycaemia in a population with impaired glucose regulation
